Status:
COMPLETED
To Evaluate the Efficacy and Feasibility of Modified Reduce-volume Target IMRT in the Treatment of Patients With Non-metastatic NPC
Lead Sponsor:
Fujian Cancer Hospital
Conditions:
Nasopharyngeal Carcinoma
Eligibility:
All Genders
Brief Summary
This is a retrospective real-world study to evaluate the efficacy and feasibility of modified reduce-volume target IMRT in the treatment of patients with non-metastatic NPC
Eligibility Criteria
Inclusion
- Pathologic diagnosis (pathologically confirmed by nasopharyngeal biopsy) was nasopharyngeal carcinoma;
- Newly diagnosed, non-metastatic and treated with modified reduce-volume IMRT;
- Patients with baseline MRI date of nasopharynx and neck, and completed the first course of treatment in our hospital;
- Diagnosis time: November 1, 2014 to December 31 , 2017
Exclusion
- Disease progression during IMRT;
- Previous malignancy or other concomitant malignant diseases;
- The evaluation information of tumor efficacy can not be obtained;
- Receive blind treatment in other clinical research.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2020
Estimated Enrollment :
471 Patients enrolled
Trial Details
Trial ID
NCT04387266
Start Date
June 1 2020
End Date
October 1 2020
Last Update
October 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of radiation oncology, Fujian cancer hospital
Fuzhou, Fujian, China, 350014